This database contains basic demographics of all patients and all mandatory registered visits and admission to our hospitals.
Table 1 shows the basic demographics of the patients who were included for analysis and demonstrates that the balance of males and females and different ages at exposure was maintained.
In summary, our findings show that while the basic demographics of the selected patients with HF-REF enrolled in PARADIGM-HF differ little from those in SOLVD-T, the potential benefit of LCZ696 over enalapril is being tested in addition to two additional disease-modifying drugs in the majority of patients in PARADIGM-HF.
For any patient Alice, a neighbour would know the basic demographics of Alice (GENDER_CODE, AGE_GROUP, and PROV_ALL).
A table of the basic demographics of the subjects used is listed in Table 1.
Basic demographics of participants: Seventy-eight of the 100 students (78%) participated in the study.
The elements of the database included basic demographic data of patients and prognosticators previously reported in literature, as well as follow-up data including clinical outcome after treatment.
Patient characteristics (including basic demographics and patient experience of hospital care) that might be associated with such attitudes were also recorded (ie, age, sex, ethnicity, occupation, surgical procedure admitted for, general or local anaesthetic, number of previous operations, and any previous experience of medical error).
Basic demographics and patient characteristics are reported using descriptive statistics.
We obtained comprehensive data concerning drug use, NPS profile and basic demographic characteristics of these patients, enabling a representative overview of the use of anti-dementia drugs and NPS in two different care settings.
